Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05017974 · ClinicalTrials.gov registry record · NA
Research on Improving Sleep During Pregnancy
A NA study of Sleep and Pregnancy Related, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT05017974: Completed NA study of Sleep and Pregnancy Related, sponsored by University of California, San Francisco.
NCT05017974 is a NA study of Sleep and Pregnancy Related that has completed, run by University of California, San Francisco. The registered enrollment target is 52 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05017974, a NA study of Sleep and Pregnancy Related, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal is to utilize a randomized control design to examine acceptability, feasibility, and adherence of mindfulness-based stress reduction plus prenatal sleep supplement (MBSR+PS) compared to treatment as usual among pregnant people with poor sleep quality (n=50).
Primary Outcome
The Client Satisfaction Questionnaire (CSQ-8) score ranges from 8 to 32, with high scores indicating greater satisfaction. The CSQ-8 score of participants randomized to MBSR+PS will be reported; participants randomized to TAU will not complete the CSQ-8 as the questions pertain to the MBSR+PS program.
Conditions Studied
Interventions
- OTHER Treatment as Usual
- BEHAVIORAL Mindfulness-Based Stress Reduction plus Prenatal Sleep supplement
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2021-09-08 |
| Est. Completion | 2022-07-14 |
| Phase | NA |
What the finished NCT05017974 record still lists
NCT05017974 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT05017974 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05017974 about?
NCT05017974 is a clinical study titled "Research on Improving Sleep During Pregnancy". The overarching goal is to utilize a randomized control design to examine acceptability, feasibility, and adherence of mindfulness-based stress reduction plus prenatal sleep supplement (MBSR+PS) compared to treatment as usual among pregnant people with poor sleep quality (n=50).
What is the current status of trial NCT05017974?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2021-09-08. Estimated completion is 2022-07-14.
What conditions does trial NCT05017974 study?
This clinical trial studies the following conditions: Sleep, Pregnancy Related.
What interventions are being tested in trial NCT05017974?
The interventions under investigation include: Treatment as Usual (OTHER), Mindfulness-Based Stress Reduction plus Prenatal Sleep supplement (BEHAVIORAL).
Who is sponsoring clinical trial NCT05017974?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05017974 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05017974's enrollment target sits among peer trials
52 101st of 151 higher than 51 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
RECRUITING · NA
-
The Goodnight Screen Media Study
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Shifting Sleep Timing in Teens
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI